Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Amyloid beta-peptide and the dementia of Parkinson's disease.

Identifieur interne : 004C18 ( Ncbi/Checkpoint ); précédent : 004C17; suivant : 004C19

Amyloid beta-peptide and the dementia of Parkinson's disease.

Auteurs : K. Jendroska [Allemagne] ; A J Lees ; Werner Poewe [Autriche] ; S E Daniel

Source :

RBID : pubmed:8914090

English descriptors

Abstract

It is not known whether an increased incidence of dementia in patients with Parkinson's disease (PD) is due to a higher incidence of Alzheimer's disease (AD) or to "early" Alzheimer-type pathology. To determine whether amyloid beta-peptide (A beta) of AD occurs more frequently in brains of patients with PD, we examined 50 cases and 79 controls by using histoblots for A beta. Twenty-three cases with PD had dementia, including all nine with A beta distributed throughout the entire cerebral cortex; three of these cases had AD. In contrast, five of 17 controls with comparable A beta accumulation were not demented. Neither AD nor A beta deposition was increased in PD, furthermore, there was no statistical correlation between the amount of A beta and the number of Lewy bodies in cerebral cortex. In 14 patients with PD in whom dementia was unrelated to A beta, there was cerebral vascular disease (four), numerous cortical Lewy bodies (three), or hydrocephalus (two); in five further cases, dementia was not well explained by histopathologic changes. Our data found no increase of either AD or "early" Alzheimer-type pathology in cases of PD; however, a synergistic effect between the two pathologies was suggested as contributing to dementia.

DOI: 10.1002/mds.870110609
PubMed: 8914090


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:8914090

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Amyloid beta-peptide and the dementia of Parkinson's disease.</title>
<author>
<name sortKey="Jendroska, K" sort="Jendroska, K" uniqKey="Jendroska K" first="K" last="Jendroska">K. Jendroska</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, Charité, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Charité, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A J" last="Lees">A J Lees</name>
</author>
<author>
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S E" last="Daniel">S E Daniel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1996">1996</date>
<idno type="RBID">pubmed:8914090</idno>
<idno type="pmid">8914090</idno>
<idno type="doi">10.1002/mds.870110609</idno>
<idno type="wicri:Area/PubMed/Corpus">004764</idno>
<idno type="wicri:Area/PubMed/Curation">004764</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004879</idno>
<idno type="wicri:Area/Ncbi/Merge">004C18</idno>
<idno type="wicri:Area/Ncbi/Curation">004C18</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004C18</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Amyloid beta-peptide and the dementia of Parkinson's disease.</title>
<author>
<name sortKey="Jendroska, K" sort="Jendroska, K" uniqKey="Jendroska K" first="K" last="Jendroska">K. Jendroska</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurology, Charité, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Charité, Berlin</wicri:regionArea>
<placeName>
<region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A J" last="Lees">A J Lees</name>
</author>
<author>
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S E" last="Daniel">S E Daniel</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1996" type="published">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alzheimer Disease (pathology)</term>
<term>Amyloid beta-Peptides (analysis)</term>
<term>Brain (pathology)</term>
<term>Cerebral Cortex (pathology)</term>
<term>Dementia (pathology)</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Lewy Bodies (pathology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurofibrillary Tangles (pathology)</term>
<term>Parkinson Disease (pathology)</term>
<term>Reference Values</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Amyloid beta-Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Brain</term>
<term>Cerebral Cortex</term>
<term>Dementia</term>
<term>Lewy Bodies</term>
<term>Neurofibrillary Tangles</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reference Values</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">It is not known whether an increased incidence of dementia in patients with Parkinson's disease (PD) is due to a higher incidence of Alzheimer's disease (AD) or to "early" Alzheimer-type pathology. To determine whether amyloid beta-peptide (A beta) of AD occurs more frequently in brains of patients with PD, we examined 50 cases and 79 controls by using histoblots for A beta. Twenty-three cases with PD had dementia, including all nine with A beta distributed throughout the entire cerebral cortex; three of these cases had AD. In contrast, five of 17 controls with comparable A beta accumulation were not demented. Neither AD nor A beta deposition was increased in PD, furthermore, there was no statistical correlation between the amount of A beta and the number of Lewy bodies in cerebral cortex. In 14 patients with PD in whom dementia was unrelated to A beta, there was cerebral vascular disease (four), numerous cortical Lewy bodies (three), or hydrocephalus (two); in five further cases, dementia was not well explained by histopathologic changes. Our data found no increase of either AD or "early" Alzheimer-type pathology in cases of PD; however, a synergistic effect between the two pathologies was suggested as contributing to dementia.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Autriche</li>
</country>
<region>
<li>Berlin</li>
<li>Tyrol (Land)</li>
</region>
<settlement>
<li>Berlin</li>
<li>Innsbruck</li>
</settlement>
<orgName>
<li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S E" last="Daniel">S E Daniel</name>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A J" last="Lees">A J Lees</name>
</noCountry>
<country name="Allemagne">
<region name="Berlin">
<name sortKey="Jendroska, K" sort="Jendroska, K" uniqKey="Jendroska K" first="K" last="Jendroska">K. Jendroska</name>
</region>
</country>
<country name="Autriche">
<region name="Tyrol (Land)">
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W" last="Poewe">Werner Poewe</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C18 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 004C18 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:8914090
   |texte=   Amyloid beta-peptide and the dementia of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:8914090" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024